Cyclobenzaprine Hydrochloride
Product Images NDC 67296-1728

4 FDA label images from Redpharm Drug, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 67296-1728). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01)

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01)
Chemical structure of Cyclobenzaprine Hydrochloride showing the tricyclic ring system attached to a side chain with a dimethylamino group and a hydrochloride salt.*
FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02)

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02)
A table comparing the incidence of side effects including drowsiness, dry mouth, fatigue, and headache among subjects taking Cyclobenzaprine HCl tablets at 5 mg and 10 mg doses, and a placebo group. The table provides percentages for each side effect across the three groups along with the number of subjects (N) in each group.*
FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03)

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03)
A data table comparing the incidence of drowsiness, dry mouth, and dizziness in clinical studies versus a surveillance program for Cyclobenzaprine Hydrochloride 10 mg tablets. The table shows higher percentages of these side effects in clinical studies than in the surveillance program.*
FDA Label Image

Label (Cyclo 5mg)

Label (Cyclo 5mg)
Label for Cyclobenzaprine Hydrochloride 5 mg tablets, packaged as 7 tablets. The label indicates prescription use only and includes storage instructions (20-25°C). The manufacturer is InvaGen Pharmaceuticals Inc, and the distributor is RedPharm Drug, Inc. The NDC number 67296-1728-7 is shown along with lot and expiration date information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.